PKO BP Bankowy Universal Pension Society’s Neurocrine Biosciences NBIX Stock Holding History

PKO BP Bankowy Universal Pension Society’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8M	Buy	170,802 +32,000	+23%	+$4.75M	8.23%	5
2026 Q1	$18.3M	Hold	138,802	–	–	8.55%	5
2025 Q4	$19.7M	Hold	138,802	–	–	9.95%	5
2025 Q3	$19.5M	Hold	138,802	–	–	11.55%	5
2025 Q2	$17.4M	Hold	138,802	–	–	11.97%	4
2025 Q1	$15.4M	Buy	138,802 +10,000	+8%	+$1.27M	12.67%	4
2024 Q4	$17.6M	Buy	+128,802	New	+$15.9M	14.62%	3

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PKO BP Bankowy Universal Pension Society's NBIX Position: Q2 2026 in Review

PKO BP Bankowy Universal Pension Society increased its Neurocrine Biosciences (NBIX) stake by 23% in Q2 2026, buying an estimated $4.75M and bringing the position to 170,802 shares worth $28.8M. The position accounts for 8.23% of the portfolio, ranked #5.

PKO BP Bankowy Universal Pension Society first reported a position in NBIX in Q4 2024 and has held it in 7 quarters since. 774 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

PKO BP Bankowy Universal Pension Society held 170,802 shares of Neurocrine Biosciences worth $28.8M as of Q2 2026.
PKO BP Bankowy Universal Pension Society bought 32,000 Neurocrine Biosciences shares in Q2 2026, an estimated $4.75M.
Neurocrine Biosciences made up 8.23% of PKO BP Bankowy Universal Pension Society's portfolio in Q2 2026, its #5 holding.
PKO BP Bankowy Universal Pension Society first reported a position in Neurocrine Biosciences in Q4 2024 and has held it in 7 quarters since.
774 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on PKO BP Bankowy Universal Pension Society's 13F filing for Q2 2026, filed 8 Jul 2026.